Your browser doesn't support javascript.
loading
Usage Pattern of Fixed-dose Combinations at ICMR Network of Rational Use of Medicine Centres across India: Recommendations for Policymakers and Prescribers.
Ranjalkar, Jaya; Jhaj, Ratinder; Chandy, Sujith J; Ight, Heber R; Chugh, Preeta K; Tripathi, Chakra D; Badyal, Dinesh K; Balakrishnan, Sadasivam; Medhi, Bikash; Kamat, Sandhya K; Tripathi, Raakhi; Dikshit, Harihar; Roy, Sukalyan S; Chatterjee, Suparna; Bhattacharjee, Manjari; Trivedi, Niyati; Desai, Chetna; Gupta, Pooja; Roy, Atanu; Raveendran, Ramasamy; Mathaiyan, Jayanthi; Kaushal, Sandeep; Jain, Samriti; Kaul, Rajni; Kshirsagar, Nilima A.
Afiliación
  • Ranjalkar J; Senior Research Officer (former), Department of Pharmacology and Clinical Pharmacology, Christian Medical College, Vellore, Tamil Nadu;Corresponding Author.
  • Jhaj R; Additional Professor, Department of Pharmacology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh.
  • Chandy SJ; Professor and Head, Department of Pharmacology and Clinical Pharmacology, Christian Medical College.
  • Ight HR; Lecturer, Department of Pharmacy, Christian Medical College, Vellore, Tamil Nadu.
  • Chugh PK; Associate Professor.
  • Tripathi CD; Professor and Former Head of the Department, Department of Pharmacology, Vardhman Mahavir Medical College & Safdarjung Hospital, New Delhi.
  • Badyal DK; Professor and Head, Department of Pharmacology, Christian Medical College, Ludhiana, Punjab.
  • Balakrishnan S; Professor and Head, Department of Pharmacology, All India Institute of Medical Sciences, Bhopal, Madhya Pradesh.
  • Medhi B; Professor, Department of Pharmacology, Postgraduate Institute of Medical Education & Research, Chandigarh, Punjab.
  • Kamat SK; Professor and Head.
  • Tripathi R; Associate Professor, Department of Pharmacology and Therapeutics, Seth GS Medical College and KEM Hospital, Mumbai, Maharashtra.
  • Dikshit H; Professor and Head.
  • Roy SS; Associate Professor, Department of Pharmacology, Indira Gandhi Institute of Medical Science, Patna, Bihar.
  • Chatterjee S; Professor.
  • Bhattacharjee M; Pharmacovigilance Associate, Department of Pharmacology,Institute of Postgraduate Medical Education & Research, Kolkata, West Bengal.
  • Trivedi N; Professor and Head,Department of Pharmacology, Medical College Baroda, Vadodara.
  • Desai C; Professor and Head, Department of Pharmacology, B.J. Medical College, Ahmedabad, Gujarat.
  • Gupta P; Additional Professor.
  • Roy A; Ex-Research Associate, Department of Pharmacology, All India Institute of Medical Sciences, New Delhi.
  • Raveendran R; Professor and former Head.
  • Mathaiyan J; Professor and Head, Department of Pharmacology, Jawaharlal Institute of Postgraduate Medical Education & Research, Puducherry.
  • Kaushal S; Professor and Head.
  • Jain S; Resident, Department of Pharmacology, Dayanand Medical College and Hospital, Ludhiana, Punjab.
  • Kaul R; Ex-Scientist-G & Head, Division of Basic Medical Sciences, Indian Council of Medical Research, New Delhi.
  • Kshirsagar NA; Former National Chair in Clinical Pharmacology, Indian Council for Medical Research (ICMR), New Delhi; Chairperson SAG BMS, Member SAB, NIRRH, Mumbai, Maharashtra, India.
J Assoc Physicians India ; 71(2): 11-12, 2023 Feb.
Article en En | MEDLINE | ID: mdl-37354468
AIM: Irrational use of medicines is a global problem. In India, one contributing factor is the availability of a large number of fixed-dose combinations (FDCs). To improve rational use and to strengthen policies, it is important to assess the usage patterns and rationality of FDCs. METHODS: This study was conducted as part of a 1-year prospective cross-sectional analysis of prescriptions in the outpatient clinics of broad specialities from 13 tertiary care hospitals across India. Five most commonly prescribed FDCs in each center were analyzed. In addition, all the prescribed FDCs were classified as per the Kokate Committee classification and it was noted whether any of the FDCs were irrational or banned as per the reference lists released by regulatory authorities. RESULTS: A total of 4,838 prescriptions were analyzed. Of these, 2,093 (43.3%) prescriptions had at least one FDC. These 2,093 prescriptions had 366 different FDCs. Of the 366 FDCs, 241 were rational; 10 were irrational; 14 required further data generation; and the remaining 96 FDCs could not be categorized into any of the above. Vitamins and minerals/supplements, antibacterial for systemic use, and drugs for gastroesophageal reflux disease (GERD) and peptic ulcer were the most used FDCs. CONCLUSION: Based on the finding that some prescriptions contained irrational FDCs, it is recommended that a rigorous, regular, and uniform method of evaluation be implemented to approve/ban FDCs and that prescribers be periodically notified about the status of the bans.
Asunto(s)

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Hospitales Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies País/Región como asunto: Asia Idioma: En Revista: J Assoc Physicians India Año: 2023 Tipo del documento: Article

Texto completo: 1 Base de datos: MEDLINE Asunto principal: Hospitales Tipo de estudio: Observational_studies / Prevalence_studies / Risk_factors_studies País/Región como asunto: Asia Idioma: En Revista: J Assoc Physicians India Año: 2023 Tipo del documento: Article